The dynamic structure of EF-G studied by fusidic acid resistance and internal revertants

J Mol Biol. 1996 May 10;258(3):420-32. doi: 10.1006/jmbi.1996.0259.

Abstract

We have previously identified 20 different fusidic acid-resistant alleles of fusA, encoding mutant forms of the ribosomal translocase EF-G. One of these, P413L, is used here as the starting point in selections for internal revertants, identifying 20 different pseudo-wild-type forms of EF-G. We have also identified two alleles of fusA previously isolated as suppressors of 4.5 S RNA deficiency. All of these mutants are analysed in terms of their effects on the structural dynamics of EF-G. Most mutation conferring fusidic acid-resistance interfere with conformational changes of EF-G, but some may be located at a possible fusidic acid binding site. Revertants of the P413L mutations restore the function of EF-G with or without affecting the level of resistance to fusidic acid. The revertant mutations probably restore the balance between the GDP and GTP conformations of EF-G off the ribosome, and most of them are located close to the interface between the G domain and domain II. The procedure for the isolation of pseudo-wild-type forms of EF-G can be used to direct evolution progressively away from the wild-type while still maintaining the essential functions of EF-G.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Binding Sites
  • DNA Mutational Analysis
  • Directed Molecular Evolution
  • Drug Resistance, Microbial / genetics
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Escherichia coli / growth & development
  • Fusidic Acid / pharmacology*
  • Models, Molecular
  • Mutation*
  • Peptide Elongation Factor G
  • Peptide Elongation Factors / chemistry*
  • Peptide Elongation Factors / genetics
  • Protein Structure, Tertiary*
  • Protein Synthesis Inhibitors / pharmacology*
  • RNA, Ribosomal / genetics
  • Salmonella typhimurium / drug effects
  • Salmonella typhimurium / genetics
  • Salmonella typhimurium / growth & development
  • Spectinomycin / pharmacology
  • Suppression, Genetic
  • Thermus thermophilus / genetics

Substances

  • Anti-Bacterial Agents
  • Peptide Elongation Factor G
  • Peptide Elongation Factors
  • Protein Synthesis Inhibitors
  • RNA, Ribosomal
  • Fusidic Acid
  • Spectinomycin